TRUSHA PATEL: Open Payments
NPI 1548594492 · WINTER HAVEN, FL. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$942 in 35 payments from 10 companies in 2025. Trend: 2023 $500 · 2024 $410 · 2025 $942
Food & beverage: $942
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 13 | $371 |
| Novo Nordisk Inc | 9 | $304 |
| Abbott Laboratories | 3 | $80 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 3 | $67 |
| ABBVIE INC. | 2 | $34 |
| SHIELD THERAPEUTICS INC | 1 | $21 |
| Lilly USA, LLC | 1 | $20 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $15 |
| Amgen Inc. | 1 | $15 |
| Fidia Pharma USA Inc. | 1 | $15 |
Products named: AIRSUPRA, Ozempic, BREZTRI, Wegovy, FREESTYLE LIBRE 3, XIFAXAN, UBRELVY, ACCRUFER.
Industry payments across FL — which companies pay providers there.
